Funded Startups in Mecklenburg-Vorpommern
Across the 12 most recent funded entries, the largest disclosed round is Cheplapharm Arzneimittel’s $544M convertible note on 2022-10-25, which dwarfs ever…
Across the 12 most recent funded entries, the largest disclosed round is Cheplapharm Arzneimittel’s $544M convertible note on 2022-10-25, which dwarfs every other disclosed amount in the list (the next-highest disclosed is Centogene’s $45M on 2022-02-01; multiple others cluster far below $15M). Mecklenburg-Vorpommern entries also cluster strongly in finance/health-related fields and in a tight city pattern around Rostock: 8 of the 12 rows are based in Rostock (Innocent Meat on 2026-01-22; Artcline on 2025-09-13; Hepster on both 2023-07-10 and 2021-03-05; and others). Stage information is uneven: 2 rows show “undisclosed” amounts (AIM3D on 2023-07-10 and Fischer on 2023-04-03), and 5 of 12 entries use “Series Unknown” for their round type (including Arztkonsultation AK on 2024-02-20 and AIM3D on 2023-07-10). Temporally, the displayed rounds span 2021-02-24 (Sawayo seed) through 2026-01-22 (Innocent Meat seed), with the most recent two rounds landing in 2025–2026.
Most recent rounds
12 shownRelated listings
Frequently asked
Which funded rounds are outliers by disclosed size in Mecklenburg-Vorpommern, and what sits next to them?
Cheplapharm Arzneimittel’s $544M convertible note (2022-10-25) is the clear size outlier, with the next-largest disclosed amount far lower at Centogene’s $45M (2022-02-01). Most other disclosed rounds fall into the single-digit millions or below, such as Innocent Meat’s $7M (2026-01-22) and Hepster’s $11M (2023-07-10).
Does Rostock dominate the geography of these funded entries, or are multiple cities equally represented?
Rostock is over-represented: 8 of 12 rows list Rostock as the city, including Innocent Meat (2026-01-22), Artcline (2025-09-13), Hepster (2023-07-10 and 2021-03-05), and Sawayo (2021-02-24). Other cities appear only once each in the view, such as Schwerin (Arztkonsultation AK, 2024-02-20) and Greifswald (Cheplapharm Arzneimittel, 2022-10-25).
How concentrated are rounds in time within this “most recent 12” view?
There is a pronounced late-window concentration at the top of the list: the two most recent disclosed rounds are Innocent Meat on 2026-01-22 ($7M) and Artcline on 2025-09-13 ($6M). The rest extend back to 2021-02-24 (Sawayo, $2M), so the displayed set stretches over roughly five years but with the latest entries packed into 2025–2026.
What does the stage/round-type mix look like, given that series labels are inconsistently reported here?
Round types are frequently not categorized: 5 of 12 rows are marked “Series Unknown” (e.g., Arztkonsultation AK on 2024-02-20; AIM3D on 2023-07-10; Zasta on 2023-01-17). In addition, 2 rows have “undisclosed” amounts (AIM3D, 2023-07-10; Fischer, 2023-04-03), which limits comparisons by disclosed size for those specific entries.
Which sectors recur most in this list, and do they coincide with the biggest disclosed rounds?
Financial Services appears twice with Hepster (Series B on 2023-07-10 for $11M and Series A on 2021-03-05 for $10M), and Biotechnology also appears twice (Artcline as Biotechnology, 2025-09-13 for $6M; Centogene as Biotechnology, 2022-02-01 for $45M). The largest disclosed round ($544M by Cheplapharm Arzneimittel on 2022-10-25) sits under Consumer Goods rather than Biotechnology or Financial Services.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.